Medical Condition
Mild to Moderate Alzheimer’s Disease

Age
50-88

Summary Description
This is a placebo-controlled study for patients that have been diagnosed with mild to moderate Alzheimer’s Disease. This trial is being conducted at 257 sites in 4 different countries. There are 15 office visits over the course of 78 weeks.

Enrollment
Currently enrolling patients.

Select Qualifications

Key Inclusion Criteria:

• Diagnosed with mild to moderate Alzheimer’s Disease
• Age 50-88
• Caregiver is capable of attending each visit
• Fluency in language

Key Exclusion Criteria:

• Medical history involving brain/psychiatric or autoimmune disorders
• Weight > 120 kg (264 lb)

Compensation for Time and Travel
Study related care is provided.  There is compensation for time and travel. Subjects are given a patient stipend between $100 and $200 for each completed visit.

To apply for this study or attain more information, please: CONTACT OUR OFFICE